Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Detlef Schuppan

Showing results (1-10 of 409) with videos related to

Pageof 41
Sort By:
Clinics and Research in Hepatology and Gastroenterology|July 21, 2015
Liver fibrosis: Common mechanisms and antifibrotic therapiesDetlef Schuppan
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 9, 2016
[Celiac disease : Pathogenesis, clinics, epidemiology, diagnostics, therapy]Detlef Schuppan
Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru|July 26, 2002
[LIVER FIBROSIS: PATHOGENESIS,PREVENTION AND TREATMENT]Detlef Schuppan
Gastrointestinal Endoscopy Clinics of North America|April 29, 2006
Monitoring nonresponsive patients who have celiac diseaseNorbert Krauss, Detlef Schuppan
Gastroenterology|September 15, 2007
Turning swords into plowshares: transglutaminase to detoxify glutenDetlef Schuppan, Yvonne Junker
Deutsche Medizinische Wochenschrift (1946)|February 7, 2015
[Diagnostics and treatment of celiac disease]Andreas Stallmach, Detlef Schuppan
Gut|September 14, 2010
Serum fibrosis markers to predict clinical and histological progression in hepatitis C non-respondersRaza Malik, Detlef Schuppan
Digestive Diseases (Basel, Switzerland)|May 1, 2015
Wheat amylase trypsin inhibitors as nutritional activators of innate immunityDetlef Schuppan, Victor Zevallos
Journal of Hepatology|February 4, 2012
Anti-fibrotic therapy: lost in translation?Detlef Schuppan, Massimo Pinzani
Journal of Hepatology|March 4, 2020
β-arrestin: Dr Jekyll and Mr Hyde in NASH and fibrosisHiroyuki Abe, Detlef Schuppan
Pageof 41

Showing results (1-10 of 409) with videos related to

Sort By:
Pageof 41
Clinics and Research in Hepatology and Gastroenterology|July 21, 2015
Liver fibrosis: Common mechanisms and antifibrotic therapiesDetlef Schuppan
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 9, 2016
[Celiac disease : Pathogenesis, clinics, epidemiology, diagnostics, therapy]Detlef Schuppan
Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru|July 26, 2002
[LIVER FIBROSIS: PATHOGENESIS,PREVENTION AND TREATMENT]Detlef Schuppan
Gastrointestinal Endoscopy Clinics of North America|April 29, 2006
Monitoring nonresponsive patients who have celiac diseaseNorbert Krauss, Detlef Schuppan
Gastroenterology|September 15, 2007
Turning swords into plowshares: transglutaminase to detoxify glutenDetlef Schuppan, Yvonne Junker
Deutsche Medizinische Wochenschrift (1946)|February 7, 2015
[Diagnostics and treatment of celiac disease]Andreas Stallmach, Detlef Schuppan
Gut|September 14, 2010
Serum fibrosis markers to predict clinical and histological progression in hepatitis C non-respondersRaza Malik, Detlef Schuppan
Digestive Diseases (Basel, Switzerland)|May 1, 2015
Wheat amylase trypsin inhibitors as nutritional activators of innate immunityDetlef Schuppan, Victor Zevallos
Journal of Hepatology|February 4, 2012
Anti-fibrotic therapy: lost in translation?Detlef Schuppan, Massimo Pinzani
Journal of Hepatology|March 4, 2020
β-arrestin: Dr Jekyll and Mr Hyde in NASH and fibrosisHiroyuki Abe, Detlef Schuppan
Pageof 41